Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing and delivering innovative products to patients suffering from debilitating diseases such as lupus nephritis (LN).

How We’re Helping Patients

Latest News

December 28, 2016 • 12:00am EST

Aurinia Closes US$28 Million Financing

Read Press Release View All News

December 22, 2016 • 12:00am EST

Aurinia Announces US$25.0 Million Bought Deal Financing

Read Press Release View All News

December 19, 2016 • 12:00am EST

Aurinia Announces Long-Term Manufacturing Collaboration Agreement with Lonza for Clinical and Commercial Supply of Voclosporin

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today